Form 6-K Transition Therapeutics For: Nov 10

Go back to Form 6-K Transition Therapeutics For: Nov 10

Transition Therapeutics (TTHI) Misses Q3 EPS by 27c

November 12, 2014 4:20 PM EST

Transition Therapeutics (NASDAQ: TTHI) reported Q3 EPS of ($0.45), $0.27 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Transition Therapeutics (TTHI) click here.

... More